Drug-maker Mylan and its $300 "generic" EpiPen

Hosted by

Mylan might or might not have good news for people who need EpiPens. They provide quick injections to protect against potentially deadly anaphylactic shock from bee stings, peanut allergies and other sources. The drug company is still increasing the price of two EpiPens to $600 — while it also produces a so-called "generic" for $300. Andrew Pollack covers the business and science of biotechnology for the New York Times.

Credits

Guest:
Andrew Pollack - New York Times

Host:
Warren Olney

Producers:
Sáša Woodruff, Paul von Zielbauer, Jenny Hamel